Earlier this month, the House of Representatives passed the 21st Century Cures Act in a rare bi-partisan effort. The bill is meant to speed the development of lifesaving treatments, but critics warn it may also allow ineffective or even harmful drugs onto the market.
Controversy over regulating the funds for the very wealthy, and their relationship to the greater economy.
- Richard Blumenthal attorney general of Connecticut
- Jenny Anderson reporter, New York Times
- Randall Dodd director, Financial Policy Forum and the Derivatives Study Center
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
- Sebastian Mallaby director of the Maurice R. Greenberg Center for Geoeconomic Studies; deputy director of studies and Paul A. Volcker senior fellow for international economics at the Council on Foreign Relations
Most Recent Shows
Secretly-recorded videos have reopened the fight over federal funding for Planned Parenthood. We examine new hurdles for the organization, the political response and the latest in the battle over abortion rights in the U.S.
A novel about Vivian, a young Irish girl sent by rail from a New York City tenement to Minnesota in the early 1900s. She was one of thousands of abandoned children sent to live with rural families for a better life. But not all ended up in loving homes.
An estimated 11 million Americans could see their disability benefits slashed next year if Congress fails to take action. The White House and Republican lawmakers have opposing solutions. Social Security's disability fund and how to keep the program solvent.